Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study

A Zullo; V De Francesco; G Scaccianoce; Cesare Hassan; A Panarese; D Piglionica; C Panella; S Morini; E. Ierardi

doi:10.1016/j.dld.2005.01.017

Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study

A Zullo, V De Francesco, G Scaccianoce, Cesare Hassan, A Panarese, D Piglionica, C Panella, S Morini, E. Ierardi

Risultato della ricerca: Contributo in rivista › Articolo in rivista

39 Citazioni (Scopus)

Abstract

Helicobacter pylori eradication rate with standard triple therapies is decreasing. Recently, lactoferrin administration has been shown to significantly increase the cure rate of 7-day rabeprazole, clarithromycin and tinidazole triple therapy. We assessed whether lactoferrin also increases the eradication rate of 7-day esomeprazole, clarithromycin and amoxycillin triple therapy as first-line treatment.

Lingua originale	English
pagine (da-a)	496-500
Numero di pagine	5
Rivista	Digestive and Liver Disease
Volume	37
DOI	https://doi.org/10.1016/j.dld.2005.01.017
Stato di pubblicazione	Pubblicato - 2005
Pubblicato esternamente	Sì

Keywords

Amoxicillin
Anti-Bacterial Agents
Clarithromycin
Drug Therapy, Combination
Dyspepsia
Helicobacter Infections
Helicobacter pylori
Humans
Lactoferrin
Prospective Studies

Accesso al documento

10.1016/j.dld.2005.01.017

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{53b348ddbba54cd2978fe5ecddca39b4,

title = "Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study",

abstract = "Helicobacter pylori eradication rate with standard triple therapies is decreasing. Recently, lactoferrin administration has been shown to significantly increase the cure rate of 7-day rabeprazole, clarithromycin and tinidazole triple therapy. We assessed whether lactoferrin also increases the eradication rate of 7-day esomeprazole, clarithromycin and amoxycillin triple therapy as first-line treatment.",

keywords = "Amoxicillin, Anti-Bacterial Agents, Clarithromycin, Drug Therapy, Combination, Dyspepsia, Helicobacter Infections, Helicobacter pylori, Humans, Lactoferrin, Prospective Studies, Amoxicillin, Anti-Bacterial Agents, Clarithromycin, Drug Therapy, Combination, Dyspepsia, Helicobacter Infections, Helicobacter pylori, Humans, Lactoferrin, Prospective Studies",

author = "A Zullo and {De Francesco}, V and G Scaccianoce and Cesare Hassan and A Panarese and D Piglionica and C Panella and S Morini and E. Ierardi",

year = "2005",

doi = "10.1016/j.dld.2005.01.017",

language = "English",

volume = "37",

pages = "496--500",

journal = "Digestive and Liver Disease",

issn = "1590-8658",

publisher = "-Roma: Editrice Gastroenterologica Italiana. -Ospedaletto Pisa: Pacini",

}

TY - JOUR

T1 - Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study

AU - Zullo, A

AU - De Francesco, V

AU - Scaccianoce, G

AU - Hassan, Cesare

AU - Panarese, A

AU - Piglionica, D

AU - Panella, C

AU - Morini, S

AU - Ierardi, E.

PY - 2005

Y1 - 2005

N2 - Helicobacter pylori eradication rate with standard triple therapies is decreasing. Recently, lactoferrin administration has been shown to significantly increase the cure rate of 7-day rabeprazole, clarithromycin and tinidazole triple therapy. We assessed whether lactoferrin also increases the eradication rate of 7-day esomeprazole, clarithromycin and amoxycillin triple therapy as first-line treatment.

AB - Helicobacter pylori eradication rate with standard triple therapies is decreasing. Recently, lactoferrin administration has been shown to significantly increase the cure rate of 7-day rabeprazole, clarithromycin and tinidazole triple therapy. We assessed whether lactoferrin also increases the eradication rate of 7-day esomeprazole, clarithromycin and amoxycillin triple therapy as first-line treatment.

KW - Amoxicillin

KW - Anti-Bacterial Agents

KW - Clarithromycin

KW - Drug Therapy, Combination

KW - Dyspepsia

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Humans

KW - Lactoferrin

KW - Prospective Studies

KW - Amoxicillin

KW - Anti-Bacterial Agents

KW - Clarithromycin

KW - Drug Therapy, Combination

KW - Dyspepsia

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Humans

KW - Lactoferrin

KW - Prospective Studies

UR - http://hdl.handle.net/10807/34671

U2 - 10.1016/j.dld.2005.01.017

DO - 10.1016/j.dld.2005.01.017

M3 - Article

SN - 1590-8658

VL - 37

SP - 496

EP - 500

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

ER -

Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo